Clinical Trial Update: Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating letrozole in combination with imatinib mesylate for postmenopausal women with estrogen receptor–positive metastatic breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Imatinib mesylate (Imatinib)
• Letrozole (letrozole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27